Insider Transactions in Q1 2021 at Scholar Rock Holding Corp (SRRK)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2021
|
Michael Gilman |
SELL
Open market or private sale
|
Direct |
4,696
-11.14%
|
$305,240
$65.59 P/Share
|
|
Feb 08
2021
|
Michael Gilman |
SELL
Open market or private sale
|
Direct |
1,804
-4.1%
|
$117,260
$65.06 P/Share
|
|
Feb 01
2021
|
Stuart A Kingsley President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
42,000
+50.0%
|
-
|
|
Feb 01
2021
|
Edward H Myles COO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
24,150
+50.0%
|
-
|
|
Feb 01
2021
|
Yung H. Chyung Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,750
+50.0%
|
-
|
|
Feb 01
2021
|
Gregory John Carven Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,600
+50.0%
|
-
|
|
Jan 27
2021
|
Gregory John Carven Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
19,100
-15.72%
|
$1,069,600
$56.79 P/Share
|
|
Jan 27
2021
|
Gregory John Carven Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,619
+7.41%
|
$99,285
$15.11 P/Share
|
|
Jan 26
2021
|
Gregory John Carven Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
36,774
-10.9%
|
$2,169,666
$59.71 P/Share
|
|
Jan 26
2021
|
Gregory John Carven Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,900
+13.12%
|
$339,900
$11.63 P/Share
|
|
Jan 26
2021
|
Michael Gilman |
SELL
Open market or private sale
|
Direct |
3,501
-2.52%
|
$203,058
$58.97 P/Share
|
|
Jan 26
2021
|
Michael Gilman |
BUY
Exercise of conversion of derivative security
|
Direct |
3,501
+3.61%
|
$17,505
$5.77 P/Share
|